• Latest

Eisai and Seikagaku Enter into Agreement for the Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in South Korea

Tokyo, October 01, 2020: Eisai Co., Ltd. and Seikagaku Corporation announced today that the companies have entered into an agreement…